Prevention and treatment of amyloidogenic disease
DB Schenk - US Patent 6,743,427, 2004 - Google Patents
4,666.829 A 5/1987 Glenner et al. 4,713,366 A 12/1987 Stevens 5,004,697 A 4/1991
Pardridge 5,057,540 A 10/1991 Kensil et al. 5,187,153 A 2/1993 Cordell et al. 5,192,753 A …
Pardridge 5,057,540 A 10/1991 Kensil et al. 5,187,153 A 2/1993 Cordell et al. 5,192,753 A …
Passive immunization treatment of Alzheimer's disease
DB Schenk - US Patent 6,761,888, 2004 - Google Patents
5,641,474 A 6/1997 Hafler et al. and Crew LLP 5,645.820 A 7/1997 Hafler et al. 5,679.348 A
10/1997 Nesburn et al.(57) ABSTRACT 5,688,651 A 11/1997 Solomon 5,721,130 A 2/1998 …
10/1997 Nesburn et al.(57) ABSTRACT 5,688,651 A 11/1997 Solomon 5,721,130 A 2/1998 …
Humanized antibodies that recognize beta amyloid peptide
G Basi, JW Saldanha - US Patent 7,189,819, 2007 - Google Patents
US7189819B2 - Humanized antibodies that recognize beta amyloid peptide - Google Patents
US7189819B2 - Humanized antibodies that recognize beta amyloid peptide - Google Patents …
US7189819B2 - Humanized antibodies that recognize beta amyloid peptide - Google Patents …
Humanized antibodies that recognize beta amyloid peptide
G Basi, J Saldanha - US Patent 7,256,273, 2007 - Google Patents
US7256273B2 - Humanized antibodies that recognize beta amyloid peptide - Google Patents
US7256273B2 - Humanized antibodies that recognize beta amyloid peptide - Google Patents …
US7256273B2 - Humanized antibodies that recognize beta amyloid peptide - Google Patents …
Humanized and chimeric N-terminal amyloid beta-antibodies
DB Schenk, F Bard, T Yednock - US Patent 6,750,324, 2004 - Google Patents
4,666.829 A 5/1987 Glenner et al. 4,713,366 A 12/1987 Stevens 5,004,697 A 4/1991
Pardridge 5,057,540 A 10/1991 Kensil et al. 5,187,153 A 2/1993 Cordell et al. 5,192,753 A …
Pardridge 5,057,540 A 10/1991 Kensil et al. 5,187,153 A 2/1993 Cordell et al. 5,192,753 A …
N-Terminal amyloid-β antibodies
DB Schenk - US Patent 6,787,637, 2004 - Google Patents
4,666.829 A 5/1987 Glenner et al. 4,713,366 A 12/1987 Stevens 5,004,697 A 4/1991
Pardridge 5,057,540 A 10/1991 Kensil et al. 5,187,153 A 2/1993 Cordell et al. 5,192,753 A …
Pardridge 5,057,540 A 10/1991 Kensil et al. 5,187,153 A 2/1993 Cordell et al. 5,192,753 A …
Humanized antibodies that recognize beta amyloid peptide
G Basi, JW Saldanha - US Patent 7,179,892, 2007 - Google Patents
US7179892B2 - Humanized antibodies that recognize beta amyloid peptide - Google
Patents US7179892B2 - Humanized antibodies that recognize beta amyloid peptide …
Patents US7179892B2 - Humanized antibodies that recognize beta amyloid peptide …
Prevention and treatment of amyloidogenic disease
DB Schenk - US Patent 8,034,339, 2011 - Google Patents
4,666,829 A 5, 1987 Glenner et al. 4,713,366 A 12/1987 Stevens 4,816,397 A 3, 1989 BOSS
et al. 4,816,567 A 3/1989 Cabilly et al. 4,879,213 A 11, 1989 Fox et al. 4,883,666 A 11, 1989 …
et al. 4,816,567 A 3/1989 Cabilly et al. 4,879,213 A 11, 1989 Fox et al. 4,883,666 A 11, 1989 …
Passive immunization of Alzheimer's disease
DB Schenk - US Patent 6,913,745, 2005 - Google Patents
(87) PCT Pub. No.: WO00/72876 PCT Pub. Date: Dec. 7, 2000 Related US Application Data
(63) Continuation of application No. 09/585,817, filed on Jun. 1, 2000, which is a …
(63) Continuation of application No. 09/585,817, filed on Jun. 1, 2000, which is a …
Prevention and treatment of amyloidogenic disease
DB Schenk - US Patent 6,972,127, 2005 - Google Patents
The invention provides compositions and methods for treatment of amyloidogenic diseases.
Such methods entail administering an agent that induces a beneficial immune response …
Such methods entail administering an agent that induces a beneficial immune response …